An interventional study of injection of autologous nanofat grafting and microneedling with autologus nanofat graft in Scars, sponsored by Alexandria University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-11-05.
Sponsored by Alexandria University · Not applicable, Interventional, and Treatment
This study aims to evaluate the efficiency autologous nanofat injection versus autologous nanofat delivered by microneedling in management of post burn atrophic and traumatic scars.
828 studies on the registry are indexed under Atrophy; 122 are open to participants now.
This study's planned enrollment of 30 is below the median of 34 across 603 interventional studies indexed under Atrophy.
Browse Atrophy studies →Alexandria University is the lead sponsor of 569 studies on the registry; 125 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients with contractures, hypertrophic and keloid scars. 2. Patients with history of bleeding disorders or coagulopathy, or on anticoagulant therpy.
Two separate scars with similar properties or splitting of one large post-burn atrophic scar. One (part of the) scar will be treated by injection of autologous nanofat grafting and the other (part of the) scar will be treated by microneedling with autologous nanofat graft.
Procedure: injection of autologous nanofat grafting
Two separate scars with similar properties or splitting of one large post-burn atrophic scar. One (part of the) scar will be treated by injection of autologous nanofat grafting and the other (part of the) scar will be treated by microneedling with autologous nanofat graft.
Procedure: microneedling with autologus nanofat graft
Injection of nanfat graft
delivery of nanofat graft with microneedling
change in the scar by by the patient and observer scar assessment scale (POSAS).
patient and observer scar assessment scale score will be uesd
Time frame: 6 months after the proceedure
Plan to share: Yes — Upon request and as compatible by ethical considerations
Supporting information: Study protocol, Sap, Icf, Csr
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Alexandria University